|
US5204252A
(en)
*
|
1989-02-08 |
1993-04-20 |
Henkel Research Corporation |
Candida tropicalis transformation system
|
|
ES2080957T3
(en)
*
|
1990-07-13 |
1996-02-16 |
Transkaryotic Therapies Inc |
METHOD TO SCRIPT A GENOTECA.
|
|
WO1992013951A1
(en)
*
|
1991-02-04 |
1992-08-20 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Production of human serum albumin in methylotrophic yeast cells
|
|
US5866542A
(en)
*
|
1994-10-18 |
1999-02-02 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
WO1996012021A2
(en)
*
|
1994-10-18 |
1996-04-25 |
Corvas International, Inc. |
Nematode-extracted serine protease inhibitors and anticoagulant proteins
|
|
US5866543A
(en)
*
|
1995-06-05 |
1999-02-02 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
US5863894A
(en)
*
|
1995-06-05 |
1999-01-26 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
US5945275A
(en)
*
|
1994-10-18 |
1999-08-31 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
CA2202351A1
(en)
*
|
1994-10-18 |
1996-04-25 |
George Phillip Vlasuk |
Nematode-extracted serine protease inhibitors and anticoagulant proteins
|
|
US5872098A
(en)
*
|
1995-06-05 |
1999-02-16 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
MX9605082A
(en)
|
1996-10-24 |
1998-04-30 |
Univ Autonoma De Nuevo Leon |
Genetically modified methylotrophic yeasts for human growth hormone secretion production.
|
|
JP2003507006A
(en)
*
|
1999-05-20 |
2003-02-25 |
サイオス,インコーポレーテッド |
Vascular endothelial growth factor variant
|
|
JP2003500053A
(en)
*
|
1999-05-20 |
2003-01-07 |
サイオス,インコーポレーテッド |
Vascular endothelial growth factor dimer
|
|
US6440414B1
(en)
|
1999-10-01 |
2002-08-27 |
Amgen Inc. |
Pharmaceutical compositions of fibrinolytic agent
|
|
US6261820B1
(en)
*
|
1999-10-01 |
2001-07-17 |
Amgen Inc. |
Fibronolytically active polypeptide
|
|
US7033776B2
(en)
*
|
1999-12-17 |
2006-04-25 |
Amgen Inc. |
Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
|
|
WO2001077366A1
(en)
*
|
2000-04-10 |
2001-10-18 |
Cubist Pharmaceuticals, Inc. |
Positive selection method, compounds, host cells and uses thereof
|
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
|
US7863020B2
(en)
*
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
|
US7029872B2
(en)
|
2000-06-28 |
2006-04-18 |
Glycofi, Inc |
Methods for producing modified glycoproteins
|
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
|
DK1294910T3
(en)
|
2000-06-30 |
2009-03-02 |
Vib Vzw |
Protein glycosylation modification in Pichia Pastoris
|
|
EP2022799A2
(en)
|
2001-11-16 |
2009-02-11 |
Biogen Idec Inc. |
Polycistronic expression of antibodies
|
|
IL165717A0
(en)
|
2002-06-26 |
2006-01-15 |
Flanders Interuniversity Inst |
A strain of methylotrophic yeast for producing proteins
|
|
DE60335602D1
(en)
*
|
2002-12-18 |
2011-02-17 |
Roche Diagnostics Gmbh |
Recombinant deoxyribonuclease I from bovine pancreas with high specific activity
|
|
ATE387494T1
(en)
*
|
2002-12-20 |
2008-03-15 |
Hoffmann La Roche |
HEAT-LASABLE DESOXYRIBONUCLEASE I VARIANTS
|
|
US7332299B2
(en)
*
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
|
EP1460425A1
(en)
*
|
2003-03-17 |
2004-09-22 |
Boehringer Mannheim Gmbh |
Deglycosylated enzymes for conjugates
|
|
ES2337684T3
(en)
*
|
2003-12-05 |
2010-04-28 |
F. Hoffmann-La Roche Ag |
RECOMBINANT CARBOXIPEPTIDASE B AND ITS PURIFICATION.
|
|
US7588745B2
(en)
*
|
2004-04-13 |
2009-09-15 |
Si Options, Llc |
Silicon-containing products
|
|
AU2006291780B2
(en)
*
|
2005-09-14 |
2011-12-08 |
F. Hoffmann-La Roche Ag |
Cleavage of precursors of insulins by a variant of trypsin
|
|
EP2027271A4
(en)
*
|
2006-05-19 |
2010-06-09 |
Glycofi Inc |
RECOMBINANT VECTORS
|
|
EP3078743B1
(en)
|
2007-09-28 |
2020-06-24 |
Portola Pharmaceuticals, Inc. |
Antidotes for factor xa inhibitors and methods of using the same
|
|
US8067339B2
(en)
|
2008-07-09 |
2011-11-29 |
Merck Sharp & Dohme Corp. |
Surface display of whole antibodies in eukaryotes
|
|
EP2324121B1
(en)
|
2008-08-12 |
2012-11-07 |
GlycoFi, Inc. |
Improved vectors and yeast strains for protein production: ca2+ atpase overexpression
|
|
BR122012024318A2
(en)
|
2008-09-26 |
2019-07-30 |
Ambrx, Inc. |
MODIFIED ANIMAL ERYTHROPOETIN POLYPEPTIDES AND THEIR USES
|
|
FI3604510T3
(en)
|
2009-03-30 |
2025-06-26 |
Alexion Pharma Inc |
Antidotes for factor xa inhibitors and methods of using the same
|
|
WO2011008885A1
(en)
|
2009-07-15 |
2011-01-20 |
Portola Pharmaceuticals, Inc. |
Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same
|
|
AU2010307098A1
(en)
|
2009-10-16 |
2012-04-26 |
Merck Sharp & Dohme Corp. |
Method for producing proteins in Pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens
|
|
US20130011875A1
(en)
|
2009-10-30 |
2013-01-10 |
Merck Sharpe & Dohme Corp |
Methods for the production of recombinant proteins with improved secretion efficiencies
|
|
KR101930961B1
(en)
|
2010-02-24 |
2018-12-19 |
머크 샤프 앤드 돔 코포레이션 |
Method for increasing n-glycosylation site occupancy on therapeutic glycoproteins produced in pichia pastoris
|
|
JP6193220B2
(en)
|
2011-05-20 |
2017-09-06 |
アルダーバイオ・ホールディングズ・エルエルシー |
High purity production of multi-subunit proteins such as antibodies in transformed microorganisms such as Pichia pastoris
|
|
KR101978534B1
(en)
|
2011-08-19 |
2019-08-28 |
앨더바이오 홀딩스 엘엘씨 |
Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris
|
|
US20130230901A1
(en)
|
2012-02-14 |
2013-09-05 |
Portola Pharmaceuticals, Inc. |
Process for making recombinant antidote to factor xa inhibitor
|
|
JP6735561B2
(en)
|
2012-12-03 |
2020-08-05 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
O-glycosylated carboxy-terminal portion (CTP) peptide-based insulin and insulin analogs
|
|
US9944689B2
(en)
|
2013-03-07 |
2018-04-17 |
The General Hospital Corporation |
Human CTLA4 mutants and use thereof
|
|
CA2905180C
(en)
|
2013-03-15 |
2023-03-07 |
Alder Biopharmaceuticals, Inc. |
Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
|
|
CA2905531C
(en)
|
2013-03-15 |
2023-01-03 |
Alder Biopharmaceuticals, Inc. |
Antibody purification and purity monitoring
|
|
CA2917912C
(en)
|
2013-07-24 |
2019-09-17 |
Streck, Inc. |
Compositions and methods for stabilizing circulating tumor cells
|
|
US11168351B2
(en)
|
2015-03-05 |
2021-11-09 |
Streck, Inc. |
Stabilization of nucleic acids in urine
|
|
WO2017011275A1
(en)
|
2015-07-10 |
2017-01-19 |
Nersissian Aram M |
Factor viii protein compositions and methods of treating hemophilia a
|
|
HUE069884T2
(en)
|
2015-10-09 |
2025-04-28 |
Genzyme Corp |
Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting
|
|
US20170145475A1
(en)
|
2015-11-20 |
2017-05-25 |
Streck, Inc. |
Single spin process for blood plasma separation and plasma composition including preservative
|
|
US11506655B2
(en)
|
2016-07-29 |
2022-11-22 |
Streck, Inc. |
Suspension composition for hematology analysis control
|
|
TWI795373B
(en)
|
2016-10-07 |
2023-03-11 |
美商健臻公司 |
Early post-transfection isolation of cells (epic) for biologics production
|
|
EP3697209B1
(en)
|
2017-10-19 |
2024-07-24 |
Streck LLC |
Compositions for hemolysis and coagulation regulation and stabilization of extracellular vesicles
|
|
EP3505181B1
(en)
|
2017-12-28 |
2021-07-07 |
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center |
Preparation of enzyme replacement therapy for mucopolysaccharidosis iiid
|
|
US12421316B2
(en)
|
2019-02-19 |
2025-09-23 |
The Regents Of The University Of Colorado, A Body Corporate |
Bispecific immunotoxins targeting human CD25+CCR4+ tumors and regulatory T-cells
|
|
FI4010379T3
(en)
|
2019-08-08 |
2025-06-26 |
Alexion Pharma Inc |
Compositions and methods for preparing factor xa and derivatives
|
|
NL2031833B1
(en)
|
2022-05-11 |
2023-11-17 |
Univ Leiden |
Immunotherapeutic compositions and adjuvants
|
|
WO2024032891A1
(en)
|
2022-08-11 |
2024-02-15 |
Vib Vzw |
Glyco-engineered yeast for therapeutic protein production
|
|
WO2025196308A1
(en)
|
2024-03-22 |
2025-09-25 |
Vib Vzw |
Means and methods for displaying fc-containing proteins on cells and selection thereof
|